Related Experiment Video
Updated: Apr 16, 2026

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors
Published on: April 13, 2019
High-Level Difucosyllactose Biosynthesis via Metabolic and Transporter Engineering
Lizhi Zhu1,2, Caiwen Lao3, Lixia Yuan1,2
1University of Science and Technology of China, Hefei 230026, China.
This study engineered *Escherichia coli* to produce difucosyllactose (DFL), a prebiotic oligosaccharide. A record titer of 110.3 g/L was achieved through metabolic and transporter engineering, demonstrating a robust platform for industrial production.
Area of Science:
- Metabolic Engineering
- Biotechnology
- Microbial Fermentation
Background:
- Difucosyllactose (DFL) is a complex human milk oligosaccharide with significant prebiotic potential.
- Efficient biosynthesis of DFL is crucial for its industrial application.
- Existing methods for DFL production are limited in titer and efficiency.
Purpose of the Study:
- To engineer *Escherichia coli* for high-titer biosynthesis of DFL.
- To optimize the metabolic pathways and transporter systems for DFL production.
- To establish a robust platform for industrial-scale DFL manufacturing.
Main Methods:
- Engineered *Escherichia coli* using glycosyltransferases (WbgL and FutM1) for DFL synthesis.
- Optimized enzyme catalytic efficiency and gene copy numbers.
- Disrupted competing pathways (*wcaI*, *wcaH*, *nudK*) and deleted *pykA* to enhance precursor availability.
- Engineered transporters by deleting *emrE* and overexpressing *ompF*.
- Implemented continuous low-concentration lactose feeding in a 5-L bioreactor.
Main Results:
- Achieved a record-breaking DFL titer of 110.3 g/L.
- Identified optimal enzyme pair (WbgL and FutM1) and maximized their catalytic efficiency.
- Successfully redirected carbon flux and enhanced precursor availability.
- Improved synthesis efficiency through targeted transporter engineering.
- Demonstrated high-level DFL production under optimized fermentation conditions.
Conclusions:
- Systematic metabolic engineering and refined process control provide a robust platform for industrial production of complex oligosaccharides like DFL.
- The engineered *E. coli* strain and fermentation strategy represent a significant advancement in DFL manufacturing.
- This study paves the way for large-scale, cost-effective production of DFL for prebiotic applications.
Related Concept Videos
Production of Pharmaceuticals
Bioreactor Controls-III
Biosynthesis of Polysaccharides
Inducible Operons: lac Operon
Carbohydrate Absorption
After being swallowed, the partially digested carbohydrates mix with gastric secretions in the stomach. However, the acidic environment...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...

